These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 35699274

  • 1. Synthesis, characterisation, DNA binding, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activities and molecular docking studies of metal(II) complexes with 1,10-phenanthroline scaffold.
    Gladis EHE, Nagashri K, Anisha M, Joseph J.
    J Biomol Struct Dyn; 2023 Jul; 41(11):5067-5085. PubMed ID: 35699274
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, structural elucidation, DNA binding, cleavage, AChE and BuChE cholinesterase efficiencies of metal complexes with 1,10-phenanthroline scaffold.
    Gladis EHE, Nagashri K, Krishnendu A.
    Nucleosides Nucleotides Nucleic Acids; 2022 Jul; 41(3):285-313. PubMed ID: 35080488
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis, biological evaluation and molecular docking of cyclic biguanidine compounds as cholinesterase inhibitors.
    Gungor O, Kose M.
    J Biomol Struct Dyn; 2023 Dec; 41(20):10885-10899. PubMed ID: 36537267
    [Abstract] [Full Text] [Related]

  • 4. Design, Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Study of Benzimidazole-Based Oxazole Analogues: A Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors.
    Hussain R, Rahim F, Ullah H, Khan S, Sarfraz M, Iqbal R, Suleman F, Al-Sadoon MK.
    Molecules; 2023 Oct 10; 28(20):. PubMed ID: 37894494
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E, Sadeghpour H, Nadri H, Sakhteman A, Tüylü Küçükkılınç T, Miri R, Edraki N.
    Bioorg Chem; 2019 Aug 10; 89():103006. PubMed ID: 31158577
    [Abstract] [Full Text] [Related]

  • 6. A multifunctional anti-AD approach: Design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives.
    Yang A, Liu C, Zhang H, Wu J, Shen R, Kou X.
    Eur J Med Chem; 2022 Apr 05; 233():114216. PubMed ID: 35227980
    [Abstract] [Full Text] [Related]

  • 7. In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease.
    Kumar V, Saha A, Roy K.
    Comput Biol Chem; 2020 Oct 05; 88():107355. PubMed ID: 32801088
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X, Fu H, Yang S, Wang L, Liu AL, Wu S, Du GH.
    Molecules; 2017 Jul 26; 22(8):. PubMed ID: 28933746
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
    Zafar R, Naureen H, Zubair M, Shahid K, Saeed Jan M, Akhtar S, Ahmad H, Waseem W, Haider A, Ali S, Tariq M, Sadiq A.
    Drug Des Devel Ther; 2021 Jul 26; 15():2679-2694. PubMed ID: 34188447
    [Abstract] [Full Text] [Related]

  • 12. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
    Daoud I, Melkemi N, Salah T, Ghalem S.
    Comput Biol Chem; 2018 Jun 26; 74():304-326. PubMed ID: 29747032
    [Abstract] [Full Text] [Related]

  • 13. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.
    Jamal QMS, Khan MI, Alharbi AH, Ahmad V, Yadav BS.
    Nutrients; 2023 Mar 24; 15(7):. PubMed ID: 37049419
    [Abstract] [Full Text] [Related]

  • 14. Multi-target approach for Alzheimer's disease treatment: computational biomolecular modeling of cholinesterase enzymes with a novel 4-N-phenylaminoquinoline derivative reveal promising potentials.
    Adeowo FY, Ejalonibu MA, Elrashedy AA, Lawal MM, Kumalo HM.
    J Biomol Struct Dyn; 2021 Jul 24; 39(11):3825-3841. PubMed ID: 33030113
    [Abstract] [Full Text] [Related]

  • 15. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Wang DM, Feng B, Fu H, Liu AL, Wang L, Du GH, Wu S.
    Molecules; 2017 Jan 20; 22(1):. PubMed ID: 28117700
    [Abstract] [Full Text] [Related]

  • 16. Bioactivity of hamamelitannin, flavokawain A, and triacetyl resveratrol as natural compounds: Molecular docking study, anticolon cancer, and anti-Alzheimer potentials.
    Zhang M, Xue J, Chen X, Elsaid FG, Salem ET, Ghanem RA, El-Kott AF, Xu Z.
    Biotechnol Appl Biochem; 2023 Apr 20; 70(2):730-745. PubMed ID: 35933706
    [Abstract] [Full Text] [Related]

  • 17. Synthesis of indole derivatives as Alzheimer inhibitors and their molecular docking study.
    Homoud ZA, Taha M, Rahim F, Iqbal N, Nawaz M, Farooq RK, Wadood A, Alomari M, Islam I, Algheribe S, Rehman AU, Khan KM, Uddin N.
    J Biomol Struct Dyn; 2023 Nov 20; 41(19):9865-9878. PubMed ID: 36404604
    [Abstract] [Full Text] [Related]

  • 18. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
    Larik FA, Shah MS, Saeed A, Shah HS, Channar PA, Bolte M, Iqbal J.
    Int J Biol Macromol; 2018 Sep 20; 116():144-150. PubMed ID: 29729344
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and molecular modelling of thiadizole based hydrazone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitory activities.
    Işık A, Acar Çevik U, Karayel A, Celik I, Erçetin T, Koçak A, Özkay Y, Kaplancıklı ZA.
    SAR QSAR Environ Res; 2022 Mar 20; 33(3):193-214. PubMed ID: 35243936
    [Abstract] [Full Text] [Related]

  • 20. Search for new multi-target compounds against Alzheimer's disease among histamine H3 receptor ligands.
    Bajda M, Łażewska D, Godyń J, Zaręba P, Kuder K, Hagenow S, Łątka K, Stawarska E, Stark H, Kieć-Kononowicz K, Malawska B.
    Eur J Med Chem; 2020 Jan 01; 185():111785. PubMed ID: 31669851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.